The Alliance is directly accountable to the National Cancer Transformation Board through NHS England, which sets the scope of the Cancer Alliance and influences its ways of working. This includes access to national Cancer Transformation Funding, which is routed through Cancer Alliances around the country.
As the cancer priority work programme of the Health and Care Partnership, the Cancer Alliance also reports to the West Yorkshire and Harrogate Association of Acute Trusts (WYAAT), the Joint Committee of West Yorkshire and Harrogate Clinical Commissioning Groups and the Clinical Forum for the delivery of the jointly agreed programme ambitions.
Role and Membership of the Cancer Alliance Board
Our stakeholder Alliance Board was established in November 2016, in line with the guidance produced by NHS England, to oversee the development of one single Cancer Delivery Plan for West Yorkshire and Harrogate, aligned to the work of the WYH Health and Care Partnership.
The role of the Board has been to provide system leadership, direction and assurance for the delivery of the ambitions of the national cancer strategy, on behalf of the health and care system leadership across the region. Through the oversight and challenge of the Alliance's five project groups,
Membership of the Board is drawn from organisations and agencies from across West Yorkshire and Harrogate to create the multidisciplinary skill mix required to deliver the cancer programme and is not intended to be comprehensively representative of the sectors from which our Alliance partners are drawn.
Clive Kay, Chief Executive of Bradford Teaching Hospitals NHS Foundation Trust, and Amanda Bloor, Chief Officer, Harrogate and Rural District Clinical Commissioning Group, are provider and commissioner Senior Responsible Officers (SROs) respectively. Clive is also Chair of the Alliance Board.
The Board is currently being reconstituted and a full list of members will be available shortly.
A sixth programme strand focuses on Commissioning for Outcomes. Discussions are currently taking place with the West Yorkshire and Harrogate Joint Committee of Clinical Commissioning Groups and the West Yorkshire Association of Acute Trusts about a Cancer Alliance framework which supports the development of ambitious but realistic local plans to improve the care and support available to those affected by cancer. This developing work has a clear focus on improving outcomes for patients, based on the priorities reflected in our workstreams listed above.